You've treated the infection, yet fatigue persists. Your genes may explain why.

Your MTHFR gene produces an enzyme that converts dietary folate and B12 into their active forms (methylfolate and methylcobalamin). These active forms are essential cofactors in the methylation cycle, which produces energy at the cellular level, builds neurotransmitters, and regulates inflammation. Without functional MTHFR, your cells are running on empty.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 40-70%. This means even a perfect diet leaves your cells functionally depleted of the B vitamins needed for ATP production. You can eat organic vegetables and take supplements, but if the conversion step is broken, the fuel never reaches your mitochondria.

For post-Lyme patients, this is catastrophic. Lyme disease already depletes cellular energy reserves through chronic mitochondrial stress and inflammation. Add a MTHFR variant, and your cells can’t rebuild. You feel perpetually exhausted despite adequate sleep. Your brain fog won’t clear. You crash after minimal exertion. Your body is literally unable to generate the ATP needed to feel human again.

Your VDR gene codes for the vitamin D receptor, a protein that sits on cell membranes and lets vitamin D enter the cell. Once inside, vitamin D regulates hundreds of processes, including mitochondrial biogenesis (building new energy factories), immune tolerance, and calcium metabolism. Without a functioning VDR, vitamin D passes through your body without doing its job.

VDR variants like BsmI and FokI are extremely common, affecting roughly 30-50% of the population. These variants reduce cellular uptake of vitamin D, meaning high blood levels of vitamin D don’t translate into cellular benefit. You can supplement aggressively and still be functionally deficient at the mitochondrial level. This is why some Lyme patients feel no better despite vitamin D supplementation.

For post-Lyme recovery, VDR dysfunction is particularly damaging. Lyme disease exhausts mitochondria through years of chronic immune activation. Vitamin D is one of the few molecules that can trigger mitochondrial repair and rebuild. If your VDR can’t absorb it, that repair mechanism is blocked. You’re left stuck with damaged mitochondria that can’t produce energy, driving the relentless fatigue that characterizes post-Lyme syndrome.

Your SOD2 gene produces manganese superoxide dismutase (MnSOD), an enzyme that lives inside mitochondria and neutralizes superoxide, one of the most destructive free radicals. Superoxide is generated as a byproduct of normal energy production. If it’s not neutralized immediately, it damages mitochondrial DNA, proteins, and membranes. Over time, this damage accumulates and mitochondria fail.

The SOD2 Val16Ala variant, present in roughly 40% of people with European ancestry, reduces MnSOD activity. This means oxidative damage accumulates in your mitochondria faster than your body can repair it. You experience this as progressive energy loss, worsening fatigue with exertion, and post-exertional malaise (crashing hard after minor activity).

Lyme disease creates massive oxidative stress. The immune system generates reactive oxygen species to fight the bacteria. Even after the infection is cleared, inflammation continues generating free radicals. If you carry an SOD2 variant, your mitochondria are being bombarded with oxidative damage while your defenses are weakened. This is why some post-Lyme patients experience worsening fatigue months after completing antibiotics. The mitochondria have been slowly burning out.

Your COMT gene produces an enzyme that clears dopamine, norepinephrine, and epinephrine from synapses. These are your stress neurotransmitters. They flood your bloodstream during the fight-or-flight response, preparing you to act. Once the threat passes, COMT clears them so your nervous system can relax. Without efficient COMT, these chemicals linger, keeping you in a state of sympathetic activation even when there’s no danger.

The COMT Val158Met variant creates slow metabolizers, present in roughly 25% of the population as homozygotes. Slow COMT means stress neurotransmitters don’t clear efficiently, keeping your nervous system activated during sleep when it should be in deep parasympathetic rest. You’re literally unable to downshift. Even if you sleep 9 hours, you wake exhausted because your nervous system never truly recovered.

For post-Lyme patients, this is devastating. Your body has been in fight-or-flight for months fighting infection. Now the infection is gone, but your COMT can’t clear the residual stress chemistry. You’re physiologically stuck in a state of vigilance. Your nervous system never gets the deep rest needed to rebuild. You feel wired and tired simultaneously. Adrenaline crashes hit you unpredictably. Your fatigue is compounded by a nervous system that won’t stop firing.

Your SLC6A4 gene codes for the serotonin transporter, a protein that recycles serotonin from the synapse back into neurons. Serotonin is not just a mood chemical. It’s the precursor to melatonin, the hormone that regulates your sleep-wake cycle and enables deep, restorative sleep. If serotonin recycling is inefficient, serotonin accumulates in some places and depletes in others, disrupting the melatonin production needed for sleep quality.

The SLC6A4 5-HTTLPR short allele is carried by roughly 40% of the population. This variant impairs serotonin recycling, leading to inconsistent melatonin production and non-restorative sleep. You may sleep 8 hours and wake feeling as if you slept 4. Your sleep architecture is fractured. You don’t reach deep, slow-wave sleep where cellular repair and memory consolidation occur.

Post-Lyme patients with this variant experience a particular kind of torture. Your body is desperately trying to heal from mitochondrial damage and immune dysregulation. This healing happens during slow-wave sleep. But your genetics prevent you from reaching it. You spend nights restless, waking frequently, and waking unrefreshed. Sleep becomes counterintuitive. More sleep doesn’t help because the sleep you get isn’t restorative. The fatigue compounds because cellular repair never happens.

Your TNF gene produces tumor necrosis factor-alpha, a key inflammatory cytokine. TNF is essential for fighting infection. It triggers immune cells to attack pathogens and removes dead tissue. But it must be tightly regulated. Chronic elevated TNF drives prolonged inflammation, suppresses energy metabolism, and promotes cellular exhaustion. Once TNF goes up, it’s notoriously difficult to bring back down.

The TNF -308G>A variant is carried by roughly 30% of the population. This variant increases baseline TNF-alpha production, driving chronic low-grade inflammation even when there’s no active infection. Your immune system is essentially running in overdrive at rest. This inflammatory state is energetically expensive. Chronically elevated TNF suppresses mitochondrial function, increases oxidative stress, and triggers sickness behavior (fatigue, brain fog, anhedonia).

For post-Lyme patients, this is the trap that keeps people stuck. Lyme disease causes severe TNF elevation during active infection. If you carry this TNF variant, your baseline TNF is already elevated before you get infected. After infection, TNF skyrockets. Now the bacteria is gone, but your TNF won’t come down because your genetic baseline is high. You’re left in a state of chronic inflammation that feels identical to active infection. Your fatigue, pain, and brain fog persist even though the spirochete is gone. Your immune system is attacking a ghost.